Beneficient BENF
Finance: Consumer Services · data as of November 13, 2026
Beneficient (BENF) is a financial company listed in the US with a market value of about $12M. In the twelve months to June 30, 2026 it had revenue of -$14M and net income of -$9M, a net margin of 63.2%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -11%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 50% below the current price.
About Beneficient
Beneficient is listed in the US and classified in finance: consumer services. It was profitable in 1 of the last 6 years in our data. Its share count fell by 72% over three years (buybacks).
Score: 1.2 / 5
Checks passed
- ROE above 15%
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Share count down over 3 years (buybacks)
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | -$14M | -$39M | — | -$99M | -$105M | $55M | $140M |
| Net income | -$9M | -$87M | $51M | -$2.1B | -$131M | -$63M | -$58M |
| Free cash flow | -$32M | -$39M | -$39M | -$60M | -$97M | -$61M | -$57M |
| EPS (diluted) | $-0.48 | $-4.60 | — | — | $-1.94 | $-1.84 | $-1.27 |
| Net margin | 63.2% | 223.5% | — | 2123.3% | 124.9% | -113.9% | -41.4% |
| ROIC | — | — | — | — | -14.6% | -6.5% | -3.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 1 analysts is $9.00, 1332% above the current price; targets range from $9.00 to $9.00; the consensus rating is “Strong buy”; expected EPS is $-2.60 for the fiscal year ending March 31, 2027.
Frequently asked questions
Is Beneficient stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 50% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Beneficient pay a dividend?
Not currently.
Is Beneficient a good stock to buy?
We do not give buy or sell advice. Beneficient scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.